Cough is a crucial protective reflex that helps protect the lungs and airways. However, when cough becomes chronic and ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

At the moment there are no approved therapies for suppressing refractory chronic cough, defined as lasting for eight weeks or more, which is estimated to affect somewhere between 5% and 10% of ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

US FDA approves Incyte and Syndax’s Niktimvo 9 mg & 22 mg vial sizes to treat chronic graft-versus-host disease: Wilmington, Delaware Friday, January 17, 2025, 13:30 Hrs [IST] I ...

Residents in the Tri-State area experiencing a persistent cough may be dealing with bronchitis, a common illness that often follows a cold or flu.

Boots Superintendent Pharmacist Claire Nevinson says most coughs can usually be managed at home but there are times it is ...

Rates of response to PPIs were higher in patients with likely or inconclusive GERD vs unlikely GERD as determined by the COuGH RefluX score.

BACKGROUND Cough is an important symptom of patients with chronic obstructive pulmonary disease (COPD). The cough threshold to citric acid and capsaicin in patients with COPD and in normal volunteers ...